Pharmacological treatment of Depression: Phase II Lithium addition
This study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In Netherlands
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
Multiple locations, including KnoxvilleThis study is recruiting in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.
Multiple locations, including IrvineThis study is recruiting in the United Kingdom, in Argentina, in Brazil, .... It is testing lurasidone for schizophrenia.
In United KingdomThis study is recruiting in the United States, in Argentina, in Brazil, .... It is testing treatment With Seltorexant for depression.
Multiple locations, including BirminghamThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United States. It focuses on PTSD.
Multiple locations, including TuscaloosaThis study is recruiting in Germany. It is testing Hypericum extract WS® 5570 for depression.
In GermanyThis study is recruiting. It focuses on anxiety and currently lists participation information in Germany.
In GermanyThis study is recruiting. It focuses on anxiety and currently lists participation information in France.
In ParisThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.